⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZVRA News
Zevra Therapeutics, Inc. Common Stock
Zevra’s Chief Medical Officer to Step Down for Personal Reasons as Part of Planned Transition
globenewswire.com
ZVRA
Zevra Therapeutics Announces Orange Book Listing of U.S. Patent Strengthening Exclusivity for MIPLYFFA
globenewswire.com
ZVRA
Form 8-K
sec.gov
ZVRA
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZVRA
Zevra Therapeutics to Present at the H.C. Wainwright BioConnect Investor Conference
globenewswire.com
ZVRA
Form 8-K
sec.gov
ZVRA
Zevra Reports First Quarter 2026 Financial Results and Corporate Update
globenewswire.com
ZVRA
Zevra Therapeutics Announces Details for Q1 2026 Financial Results Call
globenewswire.com
ZVRA
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZVRA
Form 8-K
sec.gov
ZVRA